It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Introduction
This study aimed to assess high healthcare utilization over 1 year in patients with axial spondyloarthritis (axSpA) and factors associated with increased healthcare utilization.
Methods
A total of 530 unselected patients with axSpA from the Atlas of Axial Spondyloarthritis in Spain—who had used at least one healthcare resource—were included in the present study. Total health care utilization was obtained from the total number of healthcare visits, medical tests, hospital admissions and emergency visits, during the 12 months prior to the survey. Linear regression was used to analyse possible factors associated with higher healthcare utilization.
Results
A total of 530 patients with axSpA participated in this study: mean age was 45.3 years and 51.1% were female. In the previous 12 months, 77.9% (n = 530) used at least one healthcare resource, with the median healthcare utilization at 25. In the multiple linear regression, the only categorical factor associated with higher healthcare utilization was female gender (β = 12.854), while the continuous factors associated with higher healthcare utilization were higher disease activity (β = 3.378), longer diagnostic delay (β = 0.959), younger age (β = − 0.737) and greater functional limitation (β = 0.576).
Conclusion
Half of patients with axSpA used 25 or more healthcare resources during 1 year. Higher healthcare utilization was associated with younger age, female gender, greater disease activity, higher functional limitation and longer diagnostic delay. Optimal monitoring of patients with axSpA may help to reduce their healthcare utilization.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 Universidad de Sevilla, Health & Territory Research (HTR), Seville, Spain (GRID:grid.9224.d) (ISNI:0000 0001 2168 1229); Spanish Federation of Spondyloarthritis Associations (CEADE), Madrid, Spain (GRID:grid.9224.d); Axial Spondiloarthritis International Federation (ASIF), London, UK (GRID:grid.9224.d)
2 Reina Sofia University Hospital, Cordoba, Spain (GRID:grid.411349.a) (ISNI:0000 0004 1771 4667); University of Cordoba, Maimonides Biomedical Research Institute of Cordoba (IMIBIC), Cordoba, Spain (GRID:grid.411901.c) (ISNI:0000 0001 2183 9102)
3 University Hospital La Paz, IdiPAZ, Madrid, Spain (GRID:grid.81821.32) (ISNI:0000 0000 8970 9163)
4 Hospital Fundación Alcorcón, Madrid, Spain (GRID:grid.81821.32)
5 Novartis Spain, Barcelona, Spain (GRID:grid.476612.0) (ISNI:0000 0004 1763 6240)
6 Hospital Universitari Parc Taulí, Sabadell, Spain (GRID:grid.428313.f) (ISNI:0000 0000 9238 6887)
7 Hospital Universitari Parc Taulí, Sabadell, Spain (GRID:grid.428313.f) (ISNI:0000 0000 9238 6887); I3PT, Medicine Department UAB, Barcelona, Spain (GRID:grid.488873.8) (ISNI:0000 0004 6346 3600)